×
For best experience we recommend to activate Javascript in your browser.
STAT5A antibody (Tyr694)
The Rabbit Polyclonal anti-STAT5A antibody has been validated for WB, IHC and ELISA. It is suitable to detect STAT5A in samples from Human.
Quick Overview for STAT5A antibody (Tyr694) (ABIN2152376)
Target
See all STAT5A Antibodies
STAT5A
(Signal Transducer and Activator of Transcription 5A (STAT5A))
Reactivity
All reactivities for STAT5A antibodies
Human
Host
All hosts for STAT5A antibodies
Rabbit
Clonality
All clonalities for STAT5A antibodies
Polyclonal
Conjugate
All conjugates for STAT5A antibodies
This STAT5A antibody is un-conjugated
Application
All applications for STAT5A antibodies
Western Blotting (WB), Immunohistochemistry (IHC), ELISA
Product Details anti-STAT5A Antibody
(hide)
Binding Specificity
All epitopes for STAT5A antibodies
Tyr694
Purification
Purified
Immunogen
STAT5A antibody was raised in Rabbit using synthesized non-phosphopeptide derived from human STAT5A around the phosphorylation site of Tyr694 as the immunogen
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
WB: 1:500-1:1000, IHC: 1:50-1:100, ELISA: 1:20000
Restrictions
For Research Use only
Handling
(hide)
Concentration
Lot specific
Buffer
PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice
Avoid repeated freeze/thaw cycles
Storage
-20 °C
Storage Comment
Store in small aliquots at -20 °C
Target Details for STAT5A
(hide)
Target
STAT5A
(Signal Transducer and Activator of Transcription 5A (STAT5A))
Alternative Name
STAT5A
Pathways
JAK-STAT Signaling , RTK Signaling , Response to Growth Hormone Stimulus , C21-Steroid Hormone Metabolic Process , Regulation of Leukocyte Mediated Immunity , Positive Regulation of Immune Effector Process , CXCR4-mediated Signaling Events , Activated T Cell Proliferation
Recently viewed
(hide)
Chat with us , powered by LiveChat